Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-022823
Filing Date
2024-09-04
Accepted
2024-09-04 20:03:07
Documents
1
Period of Report
2024-09-01

Document Format Files

Seq Description Document Type Size
1 form4-09042024_100951.html 4  
1 form4-09042024_100951.xml 4 4049
  Complete submission text file 0001415889-24-022823.txt   5436
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064
Business Address
Boudreau Philip P (Reporting) CIK: 0001805099 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-02189 | Film No.: 241279101